(E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.

IDU (5-iodo-2'-deoxyuridine), BVDU [(E)-5-(2-bromovinyl)-2'-deoxyuridine] and placebo ointments were studied for their effects on experimental herpes simplex (type 1) keratoconjuncitivitis in rabbits. When treatment was begun 65 h after virus inoculation, both BVDU and IDU prevented develo...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Maudgal, P C, De Clercq, E, Descamps, J, Missotten, L, De Somer, P, Busson, R, Vanderhaeghe, H, Verhelst, G, Walker, R T, Jones, A S
Médium: Článek
Jazyk:en
Vydáno: 1980
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC283717/
https://ncbi.nlm.nih.gov/pubmed/7352751
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC283717/
https://ncbi.nlm.nih.gov/pubmed/7352751

Podobné jednotky